Project Summary

Sacubitril Valsartan INN API is a first-in-class angiotensin receptor neprilysin inhibitor (ARNI) complex used to treat chronic heart failure. Offered in cGMP-compliant, high-purity crystalline powder form, it provides exceptional quality, full regulatory documentation (USDMF/CEP support), and batch-to-batch consistency for reliable solid oral dosage form manufacturing.